Second primary tumors in patients with head and neck cancer

Current Oncology Reports

Volumn 13, Issue 2, 2011, Pages 132-137

  Priante, Antonio Vitor Martins ^a   Castilho, Emanuel Celice ^b   Kowalski, Luiz Paulo ^c  

^a Department of Medicine   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

Head neck; Multiple primary tumors; Second primary tumors; Surveillance; Triple endoscopy

Indexed keywords

ALPHA TOCOPHEROL; FLUORINE 18; ISOTRETINOIN; PLACEBO;

CANCER INCIDENCE; CANCER LOCALIZATION; CANCER PREVENTION; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; DEVELOPING COUNTRY; DIGESTIVE SYSTEM CANCER; DISEASE FREE SURVIVAL; DOSE RESPONSE; DRUG MEGADOSE; EARLY DIAGNOSIS; ENDOSCOPY; ESOPHAGUS CANCER; HEAD AND NECK CANCER; HIGH RISK POPULATION; HUMAN; LOW DRUG DOSE; LUNG CANCER; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; REVIEW; RISK FACTOR; SECOND CANCER; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TREATMENT FAILURE;

CARCINOMA; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, SECOND PRIMARY; NEOPLASMS, SQUAMOUS CELL;

EID: 79955828433     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-010-0147-7     Document Type: Review

References (50)

1. Cancer Facts & Figures 2010 [online]. Atlanta: American Cancer Society; 2010 [cited 2010 Oct 3]. Available http://www.cancer.org/Research/ CancerFactsFigures/CancerFactsFigures/cancerfacts-and-figures-2010.
2. Mendenhall WM, Amdur RJ, Stringer SP, Villaret DB, Cassisi NJ. Radiation therapy for squamous cell carcinome of the tonsillar region: a preferred alternative to surgery? J Clin Oncol. 2000;18:2219-25.
3. Cooney TR, Poulsen MG. Is routine follow-up useful after combined-modality therapy for advanced head and neck cancer? Arch Otolaryngol Head Neck Surg. 1999;125:379-82.
4. Haas I, Hauser U, Ganzer U. The dilemma of follow-up in head and neck cancer patients. Eur Arch Otorhinolaryngol. 2001;258:177-83. (Pubitemid 32467743)
5. Vikram B, Strong EW, Shah JP, Spiro R. Second malignant neoplasms in patients successfully treated with multimodality treatment for advanced head and neck cancer. Head Neck Surg. 1984;6:734-7. (Pubitemid 14185491)
6. Sturgis EM, Miller RH. Second primary malignancies in the head and neck cancer patient. Ann Otol Rhinol Laryngol. 1995;104:946-54.
7. Franchin G, Minatel E, Gobitti C, Talamini R, Vaccher E, Sartor G, Politi D, Trovo MG, Barzan L. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients. Cancer. 2003;98:765-72. (Pubitemid 36959273)
8. Lee JH, Machtay M, McKenna MG, Weinstein GS, Markiewicz DA, Krisch RE, Kligerman MM. Radiotherapy with 6-megavolt photons for early glottic carcinoma: potential impact of extension to the posterior vocal cord. Am J Otolaryngol. 2001;22:43-54. (Pubitemid 32156415)
9. Panosetti E, Luboinski B, Mamelle G, Richard JM. Multiple synchronous and metachronous cancers of the upper aerodigestive tract: a nine-year study. Laryngoscope. 1989;99:1267-73. (Pubitemid 20012648)
10. Day GL, Blot WJ. Second primary tumors in patients with oral cancer. Cancer. 1992;70:14-9.
11. Haughey BH, Gates GA, Arfken CL, Harvey J. Meta-analysis of second malignant tumors in head and neck cancer: the case for an endoscopic screening protocol. Ann Otol Rhinol Laryngol. 1992;101:105-12.
12. Jones AS, Morar P, Phillips DE, Field JK, Husband D, Helliwell TR. Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer. 1995;75:1343-53.
13. Di Martino E, Sellhaus B, Hausmann R, Minkenberg R, Lohmann M, Esthofen MW. Survival in second primary malignancies of patients with head and neck cancer. J Laryngol Otol. 2002;116:831-8 (Pubitemid 35178012)
14. Lin K, Patel SG, Chu PY, Matsuo JM, Singh B, Wong RJ, Kraus DH, Shaha AR, Shah JP, Boyle JO. Second primary malignancy of the aerodigestive tract in patients treated for cancer of the oral cavity and larynx. Head Neck. 2005;27:1042-8. (Pubitemid 41705581)
15. Chuang SC, Scelo G, Tonita JM, Tamaro S, Jonasson JG, Kliewer EV, Hemminki K, Weiderpass E, Pukkala E, Tracey E, Friis S, Pompe-Kirn V, Brewster DH, Martos C, Chia KS, Boffetta P, Brennan P, Hashibe M. Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries. Int J Cancer. 2008;123:2390-6. This is an important review on risk factors of second primary tumors, using population-based cancer registry data.
16. Rennemo E, Zätterström U, Boysen M. Impact of second primary tumors on survival in head and neck cancer: an analysis of 2,063 cases. Laryngoscope. 2008;118:1350-6.
17. León X, del PradoVenegas M, Orús C, López M, García J, Quer M. Influence of the persistence of tobacco and alcohol use in the appearance of second neoplasm in patients with a head and neck cancer. A case-control study. Cancer Causes Control. 2009;20:645-52
18. Priante AVM, Carvalho AL, Kowalski LP. Second primary tumor in patients with upper aerodigestive tract cancer. Braz J Otorhinolaryngol. 2010;76:251-6.
19. Franco EL, Kowalski LP, Kanda JL. Risk factors for second cancers of the upper respiratory and digestive systems: a case-control study. J Clin Epidemiol. 1991;44:615-25.
20. Slaughter DP, Southwick HW, Smejkal W. "Field cancerization" in oral stratified squamous epithelium. Cancer. 1953;6:963-8.
21. Kowalski LP, Batista MB, Santos CR, Scopel AA, Salvajoli JV, Novaes PE, Trippe N. Prognostic factors in glottic carcinoma clinical stage I and II treated by surgery and radiotherapy. Am J Otolaryngol. 1993;14:122-7. (Pubitemid 23077347)
22. Warren S; Gates O. Multiple primary malignant tumors: a survey of the literature and a statistical study. Am J Cancer. 1932;16:1358-403
23. Sirtori C, Leonardelli GB, Parolari P. Plurifocalitá del cancro laringeo e significato di recidiva: studio istopatologico su cento casi. Arch Ital Oto' Rinol Laringol. 1963;74:483-98.
24. Ballantyne AJ. Principles of surgical management of cancer of the pharyngeal walls. Cancer. 1967;20:663-7.
25. Auerbach O, Stout AP, Hammond EC, Garfinkel L. Changes in bronchial epithelium in relation to cigarette smoking and in relation to lunng cancer. New Engl J Med. 1961;265:253-67.
26. Incze J, Vaughan CW Jr, Lui P, Strong MS, Kulapaditharom B. Premalignant changes in normal appearing epithelium in patients with squamous cell carcinoma of the upper aerodigestive tract. Am J Surg. 1982;144:401-5. (Pubitemid 12037509)
27. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, Corio R, Lee D, Greenberg B, Koch W, Sidransky D. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 1996;56:2488-92. (Pubitemid 26170679)
28. Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, Schantz SP, Kramer AM, Lotan R, Peters LJ, et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med. 1990;323:795-801. (Pubitemid 20303877)
29. Khuri FR, Lee JJ, Lippman SM, Kim ES, Cooper JS, Benner SE, Winn R, Pajak TF, Williams B, Shenouda G, Hodson I, Fu K, Shin DM, Vokes EE, Feng L, Goepfert H, Hong WK. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients. J Natl Cancer Inst. 2006;98:441-50.
30. Bairati I, Meyer F, Gélinas M, Fortin A, Nabid A, Brochet F, Mercier JP, Têtu B, Harel F, Mâsse B, Vigneault E, Vass S, del Vecchio P, Roy J. A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients. J Natl Cancer Inst. 2005;97:481-8. (Pubitemid 40590429)
31. van Zandwijk N, Dalesio O, Pastorino U, de Vries N, van Tinteren H. EUROSCAN, a randomized trial of vitamin A and Nacetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups. J Natl Cancer Inst. 2000;92:977-86. (Pubitemid 30469963)
32. Mayne ST, Cartmel B, Baum M, Shor-Posner G, Fallon BG, Briskin K, Bean J, Zheng T, Cooper D, Friedman C, Goodwin WJ Jr. Randomized trial of supplemental beta-carotene to prevent second head and neck cancer. Cancer Res. 2001;61:1457-63 (Pubitemid 34292573)
33. Tincani AJ, Brandalise N, Altemani A, Scanavini RC, Valério JB, Lage HT, Molina G, Martins AS. Diagnosis of superficial esophageal cancer and dysplasia using endoscopic screening with a 2% lugol dye solution in patients with head and neck cancer. Head Neck. 2000;22:170-4. (Pubitemid 30108704)
34. Hashimoto CL, Iriya K, Baba ER, Navarro-Rodriguez T, Zerbini MC, Eisig JN, Barbuti R, Chinzon D, Moraes-Filho JP. Lugol's dye spray chromoendoscopy establishes early diagnosis of esophageal cancer in patients with primary head and neck cancer. Am J Gastroenterol. 2005;100:275-82. (Pubitemid 40314509)
35. Kesting MR, Schurr C, Robitzky L, Steinstraesser L, Nieberler M, Baurecht H, Wolff KD, Loeffelbein DJ, Mücke T. Results of esophagogastroduodenoscopy in patients with oral squamous cell carcinoma-value of endoscopic screening: 10-year experience. J Oral Maxillofac Surg. 2009;67:1649-55.
36. Kesting MR, Robitzky L, Al-Benna S, Steinstraesser L, Baurecht H, Wolff KD, Hölzle F, Nieberler M, Mücke T, Loeffelbein DJ. Bronchoscopy screening in primary oral squamous cell carcinoma: a 10-year experience. Br J Oral Maxillofac Surg. 2009;47:279-83.
37. McGuirt WF, Matthews B, Koufman JA. Multiple simultaneous tumors in patients with head and neck cancer: a prospective, sequential panendoscopy study. Cancer. 1982;50:1195-9. (Pubitemid 12062904)
38. Leipzig B, Zellmer JE, Klug D. The role of endoscopy in evaluating patients with head and neck cancer. A multiinstitutional prospective study. Arch Otolaryngol. 1985;111:589-94.
39. Davidson J, Gilbert R, Irish J, Witterick I, Brown D, Birt D, Freeman J, Gullane P. The role of panendoscopy in the management of mucosal head and neck malignancy - a prospective evaluation. Head Neck. 2000;22:449-55.
40. Kerawala CJ, Bisase B, Lee J. Panendoscopy and simultaneous primary tumours in patients presenting with early carcinoma of the mobile tongue. Br J Oral Maxillofac Surg. 2009;47:363-5.
41. Guardiola E, Pivot X, Dassonville O, Poissonnet G, Marcy PY, Otto J, Poudenx M, Francois E, Bensadoun RJ, Thyss A, Demard F, Schneider M. Is routine triple endoscopy for head and neck carcinoma patients necessary in light of a negative chest computed tomography scan? Cancer. 2004;101:2028-33.
42. Shaha A, Hoover E, Marti J, Krespi Y. Is routine triple endoscopy cost-effective in head and neck cancer? Am J Surg. 1988; 155:750-3.
43. Katada C, Tanabe S, Koizumi W, Higuchi K, Sasaki T, Azuma M, Katada N, Masaki T, Nakayama M, Okamoto M, Muto M. Endoscopy. Narrow band imaging for detecting superficial squamous cell carcinoma of the head and neck in patients with esophageal squamous cell carcinoma. Endoscopy. 2010 ;42:185-90. This study describes the most promising new method for early diagnosis of second primary tumors in the esophagus.
44. Upile T, Jerjes W, Sterenborg HJ, El-Naggar AK, Sandison A, Witjes MJ, Biel MA, Bigio I, Wong BJ, Gillenwater A, MacRobert AJ, Robinson DJ, Betz CS, Stepp H, Bolotine L, McKenzie G, Mosse CA, Barr H, Chen Z, Berg K, D'Cruz AK, Stone N, Kendall C, Fisher S, Leunig A, Olivo M, Richards-Kortum R, Soo KC, Bagnato V, Choo-Smith LP, Svanberg K, Tan IB, Wilson BC, Wolfsen H, Yodh AG, Hopper C. Head & neck optical diagnostics: vision of the future of surgery. Head Neck Oncol. 2009 Jul 13;1:25.
45. Haerle SK, Strobel K, Hany TF, Sidler D, Stoeckli SJ. (18)FFDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma. Head Neck. 32(3):319-25, 2010. This study describes the impact of PET-CT on the diagnosis of second primary tumors, showing that it has more sensitivity but less specificity than panendoscopy.
46. Strobel K, Haerle SK, Stoeckli SJ, Schrank M, Soyka JD, Veit-Haibach P, Hany TF. Head and neck squamous cell carcinoma (HNSCC)-detection of synchronous primaries with (18)F-FDGPET/CT. Eur J Nucl Med Mol Imaging. 2009;36:919-27.
47. Homann N, Nees M, Conradt C, Dietz A, Weidauer H, Maier H, Bosch FX. Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary carcinoma. Clin Cancer Res. 2001;7:290-6. (Pubitemid 32183032)
48. Lei D, Sturgis EM, Liu Z, Zafereo ME, Wei Q, Li G. Genetic polymorphisms of p21 and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck. Carcinogenesis. 2010;31:222-7.
49. Li F, Sturgis EM, Zafereo ME, Liu Z, Wang LE, Wei Q, Li G. p73 G4C14-to-A4T14 polymorphism and risk of second primary malignancy after index squamous cell carcinoma of head and neck. Int J Cancer. 2009;125:2660-5.
50. Zafereo ME, Sturgis EM, Aleem S, Chaung K, Wei Q, Li G. Glutathione S-transferase polymorphisms and risk of second primary malignancy after index squamous cell carcinoma of the head and neck. Cancer Prev Res (Phila). 2009;2:432-9.